Tiziana Life Sciences (TLSA) Operating Leases (2019 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Operating Leases of $234000.0 for Q4 2025, up 120.75% year-over-year from $106000.0 in Q4 2024, and up 120.75% quarter-over-quarter from $106000.0 in Q4 2024.
Tiziana Life Sciences (TLSA) Operating Leases (2019 - 2025) Analysis & Trends
Tiziana Life Sciences' Operating Leases history runs 7 years deep, the most recent figure standing at $234000.0 for Q4 2025.
- In Q4 2025, Operating Leases rose 120.75% year-over-year to $234000.0; the TTM figure through Dec 2025 stood at $234000.0 (up 120.75% YoY), while the FY2025 annual figure was $234000.0, up 120.75% from the prior year.
- Operating Leases for Q4 2025 stood at $234000.0, up from $106000.0 in the prior quarter.
- The five-year high for Operating Leases was $420000.0 in Q2 2021, with the low at $106000.0 in Q4 2024.
- The 5-year median for Operating Leases is $130000.0 (2022), against an average of $199800.0.
- The sharpest annual moves came in 2023 and 2025: Operating Leases slipped 16.15% in 2023, then surged 120.75% in 2025.
- Tiziana Life Sciences' Operating Leases stood at $420000.0 in 2021, then tumbled by 69.05% to $130000.0 in 2022, then retreated by 16.15% to $109000.0 in 2023, then declined by 2.75% to $106000.0 in 2024, then surged by 120.75% to $234000.0 in 2025.
- Business Quant data shows TLSA's Operating Leases at $234000.0 in Q4 2025, $106000.0 in Q4 2024, and $109000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 234,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Jun 30, 2021 | 420,000.00 |
| Dec 31, 2020 | 257,487.95 |
| Jun 30, 2020 | 399,825.98 |
| Dec 31, 2019 | 272,573.68 |
| Jun 30, 2019 | 111,909.20 |